LifeStance Health Group Future Growth
Future criteria checks 4/6
LifeStance Health Group is forecast to grow earnings and revenue by 98.8% and 13% per annum respectively. EPS is expected to grow by 102.9% per annum. Return on equity is forecast to be 1.8% in 3 years.
Key information
98.8%
Earnings growth rate
102.90%
EPS growth rate
| Healthcare earnings growth | 13.6% |
| Revenue growth rate | 13.0% |
| Future return on equity | 1.76% |
| Analyst coverage | Good |
| Last updated | 16 May 2025 |
Recent future growth updates
Recent updates
LifeStance Health Group: Solid Execution Drives Growth And Margin Expansion
Apr 22
Planned Expansions And Clinician-Focused Initiatives Will Improve Future Productivity
Standardizing operations and digital initiatives should enhance efficiency, improve net margins, and boost revenue per visit.LifeStance Health Group (NASDAQ:LFST) Is Carrying A Fair Bit Of Debt
Mar 21
LifeStance Health Group, Inc.'s (NASDAQ:LFST) Share Price Matching Investor Opinion
Jan 16Should You Think About Buying LifeStance Health Group, Inc. (NASDAQ:LFST) Now?
Dec 26LifeStance Health Group (NASDAQ:LFST) Is Making Moderate Use Of Debt
Dec 05Calculating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST)
Nov 10Why Investors Shouldn't Be Surprised By LifeStance Health Group, Inc.'s (NASDAQ:LFST) P/S
Sep 26Here's Why LifeStance Health Group (NASDAQ:LFST) Can Afford Some Debt
Sep 02LifeStance Health Group, Inc. (NASDAQ:LFST) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 11LifeStance Health Group, Inc.'s (NASDAQ:LFST) Intrinsic Value Is Potentially 63% Above Its Share Price
Jul 15With LifeStance Health Group, Inc. (NASDAQ:LFST) It Looks Like You'll Get What You Pay For
Jun 07LifeStance: Selloff Opens Buying Opportunity Thanks To Price/Value Dislocation
May 23LifeStance Health Group, Inc. (NASDAQ:LFST) Analysts Are Pretty Bullish On The Stock After Recent Results
May 12Why LifeStance Health Group, Inc. (NASDAQ:LFST) Could Be Worth Watching
May 06Calculating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST)
Mar 23LifeStance Health Group, Inc. (NASDAQ:LFST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$8.50
Mar 02LifeStance Q4 Earnings Review: Monetizing Mental Health Virtually Is Problematic
Feb 29Does LifeStance Health Group (NASDAQ:LFST) Have A Healthy Balance Sheet?
Feb 28LifeStance Health Group, Inc.'s (NASDAQ:LFST) P/S Still Appears To Be Reasonable
Jan 23What Is LifeStance Health Group, Inc.'s (NASDAQ:LFST) Share Price Doing?
Jul 08Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 1,849 | 96 | 145 | N/A | 3 |
| 12/31/2026 | 1,610 | 11 | 110 | 126 | 8 |
| 12/31/2025 | 1,414 | -17 | 53 | 86 | 8 |
| 3/31/2025 | 1,284 | -36 | 102 | 126 | N/A |
| 12/31/2024 | 1,251 | -57 | 86 | 107 | N/A |
| 9/30/2024 | 1,206 | -95 | 35 | 62 | N/A |
| 6/30/2024 | 1,156 | -151 | -18 | 14 | N/A |
| 3/31/2024 | 1,104 | -173 | -69 | -31 | N/A |
| 12/31/2023 | 1,056 | -186 | -57 | -17 | N/A |
| 9/30/2023 | 1,004 | -188 | -37 | 2 | N/A |
| 6/30/2023 | 959 | -164 | -11 | 33 | N/A |
| 3/31/2023 | 909 | -187 | -17 | 42 | N/A |
| 12/31/2022 | 860 | -216 | -26 | 53 | N/A |
| 9/30/2022 | 820 | -277 | -60 | 48 | N/A |
| 6/30/2022 | 776 | -360 | -89 | 28 | N/A |
| 3/31/2022 | 727 | -361 | -109 | 3 | N/A |
| 12/31/2021 | 668 | -344 | -85 | 9 | N/A |
| 9/30/2021 | 596 | -515 | -83 | -17 | N/A |
| 6/30/2021 | 524 | -397 | -44 | 8 | N/A |
| 3/31/2021 | 447 | -331 | -42 | -1 | N/A |
| 12/31/2020 | 377 | -286 | -47 | -9 | N/A |
| 12/31/2019 | 213 | -59 | 3 | 17 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LFST is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Earnings vs Market: LFST is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: LFST is expected to become profitable in the next 3 years.
Revenue vs Market: LFST's revenue (13% per year) is forecast to grow faster than the US market (8.6% per year).
High Growth Revenue: LFST's revenue (13% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LFST's Return on Equity is forecast to be low in 3 years time (1.8%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/25 00:56 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
LifeStance Health Group, Inc. is covered by 12 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stephanie Davis | Barclays |
| Richard Close | Canaccord Genuity |
| Jamie Perse | Goldman Sachs |